Whole Body MRI in Oncology
Recruiting
Observational Study
Lymphoma
Advanced Prostate Cancer
Advanced Breast Cancer
Monoclonal Gammopathy of Undetermined Significance
Smoldering Multiple Myeloma
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
* Participant is willing and able to give informed consent for participation in the study.
* Male or Female, aged ≥ 18 years.
* Life expectancy greater than 3 months.
Exclu…
Contacts